BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

110 related articles for article (PubMed ID: 15998051)

  • 1. Phosphorylation of an alpha-synuclein peptide fragment enhances metal binding.
    Liu LL; Franz KJ
    J Am Chem Soc; 2005 Jul; 127(27):9662-3. PubMed ID: 15998051
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Structural transformation and aggregation of human alpha-synuclein in trifluoroethanol: non-amyloid component sequence is essential and beta-sheet formation is prerequisite to aggregation.
    Li HT; Du HN; Tang L; Hu J; Hu HY
    Biopolymers; 2002 Aug; 64(4):221-6. PubMed ID: 12115139
    [TBL] [Abstract][Full Text] [Related]  

  • 3. The aggregation and membrane-binding properties of an alpha-synuclein peptide fragment.
    Madine J; Doig AJ; Middleton DA
    Biochem Soc Trans; 2004 Dec; 32(Pt 6):1127-9. PubMed ID: 15506987
    [TBL] [Abstract][Full Text] [Related]  

  • 4. A topological model of the interaction between alpha-synuclein and sodium dodecyl sulfate micelles.
    Bisaglia M; Tessari I; Pinato L; Bellanda M; Giraudo S; Fasano M; Bergantino E; Bubacco L; Mammi S
    Biochemistry; 2005 Jan; 44(1):329-39. PubMed ID: 15628875
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Beta-synuclein exhibits chaperone activity more efficiently than alpha-synuclein.
    Lee D; Paik SR; Choi KY
    FEBS Lett; 2004 Oct; 576(1-2):256-60. PubMed ID: 15474047
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Phosphorylated alpha-synuclein in normal mouse brain.
    Hirai Y; Fujita SC; Iwatsubo T; Hasegawa M
    FEBS Lett; 2004 Aug; 572(1-3):227-32. PubMed ID: 15304353
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Inhibition of fibril formation and toxicity of a fragment of alpha-synuclein by an N-methylated peptide analogue.
    Bodles AM; El-Agnaf OM; Greer B; Guthrie DJ; Irvine GB
    Neurosci Lett; 2004 Apr; 359(1-2):89-93. PubMed ID: 15050719
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Phosphorylation-dependent metal binding by alpha-synuclein peptide fragments.
    Liu LL; Franz KJ
    J Biol Inorg Chem; 2007 Feb; 12(2):234-47. PubMed ID: 17082919
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Structural determinants of PLD2 inhibition by alpha-synuclein.
    Payton JE; Perrin RJ; Woods WS; George JM
    J Mol Biol; 2004 Apr; 337(4):1001-9. PubMed ID: 15033366
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Role of alpha-synuclein carboxy-terminus on fibril formation in vitro.
    Murray IV; Giasson BI; Quinn SM; Koppaka V; Axelsen PH; Ischiropoulos H; Trojanowski JQ; Lee VM
    Biochemistry; 2003 Jul; 42(28):8530-40. PubMed ID: 12859200
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Alpha-synuclein has structural and functional similarities to small heat shock proteins.
    Kim TD; Choi E; Rhim H; Paik SR; Yang CH
    Biochem Biophys Res Commun; 2004 Nov; 324(4):1352-9. PubMed ID: 15504363
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Products of Cu(II)-catalyzed oxidation of alpha-synuclein fragments containing M1-D2 and H50 residues in the presence of hydrogen peroxide.
    Kowalik-Jankowska T; Rajewska A; Jankowska E; Grzonka Z
    Dalton Trans; 2008 Feb; (6):832-8. PubMed ID: 18239841
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Cloning, expression, purification, and spectroscopic analysis of the fragment 57-102 of human alpha-synuclein.
    Bisaglia M; Trolio A; Tessari I; Bubacco L; Mammi S; Bergantino E
    Protein Expr Purif; 2005 Jan; 39(1):90-6. PubMed ID: 15596364
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Copper(II) binding by fragments of alpha-synuclein containing M1-D2- and -H50-residues; a combined potentiometric and spectroscopic study.
    Kowalik-Jankowska T; Rajewska A; Jankowska E; Grzonka Z
    Dalton Trans; 2006 Nov; (42):5068-76. PubMed ID: 17060993
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Identification of novel phosphorylation sites on postsynaptic density proteins.
    Jaffe H; Vinade L; Dosemeci A
    Biochem Biophys Res Commun; 2004 Aug; 321(1):210-8. PubMed ID: 15358237
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Products of Cu(II)-catalyzed oxidation of the N-terminal fragments of alpha-synuclein in the presence of hydrogen peroxide.
    Kowalik-Jankowska T; Rajewska A; Jankowska E; Wiśniewska K; Grzonka Z
    J Inorg Biochem; 2006 Oct; 100(10):1623-31. PubMed ID: 16839607
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Cleavage of alpha-synuclein by calpain: potential role in degradation of fibrillized and nitrated species of alpha-synuclein.
    Mishizen-Eberz AJ; Norris EH; Giasson BI; Hodara R; Ischiropoulos H; Lee VM; Trojanowski JQ; Lynch DR
    Biochemistry; 2005 May; 44(21):7818-29. PubMed ID: 15909996
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Mapping long-range interactions in alpha-synuclein using spin-label NMR and ensemble molecular dynamics simulations.
    Dedmon MM; Lindorff-Larsen K; Christodoulou J; Vendruscolo M; Dobson CM
    J Am Chem Soc; 2005 Jan; 127(2):476-7. PubMed ID: 15643843
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Site-specific interactions of Cu(II) with alpha and beta-synuclein: bridging the molecular gap between metal binding and aggregation.
    Binolfi A; Lamberto GR; Duran R; Quintanar L; Bertoncini CW; Souza JM; Cerveñansky C; Zweckstetter M; Griesinger C; Fernández CO
    J Am Chem Soc; 2008 Sep; 130(35):11801-12. PubMed ID: 18693689
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Calcium(II) selectively induces alpha-synuclein annular oligomers via interaction with the C-terminal domain.
    Lowe R; Pountney DL; Jensen PH; Gai WP; Voelcker NH
    Protein Sci; 2004 Dec; 13(12):3245-52. PubMed ID: 15537754
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 6.